AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Viglida-M Tablet

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Viglida-M Tablet

Duo-Control tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Duo-Control may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and other medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under physician supervision. Effective blood sugar control mitigates the risk of future complications. Continued adherence to your prescribed diet and exercise regimen is vital. Lifestyle choices significantly impact diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Drug interactions are possible; disclose all medications to ensure treatment safety. Alcohol should be limited due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Viglida-M Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Viglida-M Tablet

Managing type 2 diabetes

Major Benefits of Viglida-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Viglida-M Tablet with a meal.

Common Side effects of Viglida-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Viglida-M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Viglida-M Tablet with a meal.

How Viglida-M Tablet works:

Viglida-M tablets contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Viglida-M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Viglida-M Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Viglida-M Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Viglida-M Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Viglida-M Tablets is potentially hazardous for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Viglida-M Tablet :

Should you forget a Viglida-M Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Viglida-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Viglida-M Tablet

Viglida-M Tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Nausea and vomiting are possible side effects of Viglida-M Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always discuss taking any other medication with your doctor.
Viglida-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Viglida-M Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18 years old.
Viglida-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding Viglida-M in patients with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Viglida-M and seek immediate medical attention.
Prolonged Viglida-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach, potentially causing anemia and neurological issues if left unaddressed.
Viglida-M Tablet is safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (especially if you also take insulin or sulphonylurea). Report any persistent issues to your doctor.
Viglida-M Tablet
152
MRP 176
13% off